ImmunoGen
(NASDAQ) IMGN
ImmunoGen Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$287.61M
Net Income (TTM)
$73.07M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IMGN News
Why ImmunoGen Stock Soared Today
IMGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ImmunoGen
Industry
Biotechnology
Sector
Health CareEmployees
277
CEO
Mark Joseph Enyedy
Website
www.immunogen.comHeadquarters
Waltham, MA 02451-1477, US
IMGN Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-93%
Return on Capital
-97%
Return on Assets
-64%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$108.61M
Operating Income
$220.89M
EBITDA
$215.76M
Operating Cash Flow
$229.80M
Capital Expenditure
$1.36M
Free Cash Flow
$231.17M
Cash & ST Invst.
$275.14M
Total Debt
$15.24M
ImmunoGen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$113.42M
+637.7%
Gross Profit
$111.27M
+644.2%
Gross Margin
98.10%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
277
N/A
Net Income
$30.75M
+139.4%
EBITDA
$31.06M
+139.8%
Quarterly Fundamentals
Net Cash
$533.42M
+81.9%
Accounts Receivable
$130.69M
+3018.4%
Inventory
$5.50M
N/A
Long Term Debt
$72.11M
+490.3%
Short Term Debt
$24.85M
-724.3%
Return on Assets
-63.89%
N/A
Return on Invested Capital
-97.28%
N/A
Free Cash Flow
$1.42M
+102.2%
Operating Cash Flow
$2.77M
+104.3%